Close
Smartlab Europe
Achema middle east

News

Securing A Sustainable Future For The Biopharma Industry

As part of the worldwide efforts to address climate change, the biopharma industry happens to be committed to decarbonizing its operations and, at the same time, making manufacturing more sustainable. In order to support this seismic shift, they happen...

LogiPharma Highlights Key Sponsors for 2024 Event

With LogiPharma, the world’s leading life sciences supply chain event, only weeks away, organisers are highlighting some of the sponsors and exhibitors who are key to building the event’s reputation as a platform for building industry connections across the...

Bora Pharmaceuticals completes the acquisition of Upsher-Smith

Bora Pharmaceuticals Co., Ltd announced that it has completed the acquisition of Upsher-Smith  Laboratories, Inc. (“Upsher-Smith”), a generics manufacturer and marketer based in Minnesota, U.S.,  from its sellers, Sawai Group Holdings and Sumitomo Corporation of Americas. Upsher-Smith now is a...

Recovery of Biotech Funding Inevitable, Says Recent Survey

The recent survey from GlobalData- The State of the Biopharmaceutical Industry 2024, went on to reveal that 44% of the healthcare industry professionals that were surveyed globally happen to be optimistic or very optimistic when it comes to the...

Continuous Bioprocessing Shapes Biopharma Manufacturing

The biopharmaceutical industry happens to be experiencing a massive shift toward continuous bioprocessing. Unlike traditional batch processing, which happens to be involving discrete stages with intermediate holding tanks, consistent bioprocessing operates seamlessly. Cells get grown, and the desired product...

Biotherapeutic Drug Creation – Analytics, Mass Spec Lay Path

In the modern era, biopharmaceutical discovery and development scientists happen to be achieving new levels when it comes to structural insight into therapeutic proteins. By way of utilizing biopharmaceutical analytical technology as well as mass spectrometry, laboratories happen to...

Equitable Access In Pandemics – Biopharma Steps Up Its Worth

The 77th World Health Assembly- WHA goes on to mark the deadline for the conclusion of a pandemic agreement as well as amended International Health Regulations 2005 that look to make the planet much better prepared for the next...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »